TITLE

FDA creates task force to better communicate with public

PUB. DATE
July 2009
SOURCE
Cardiology Today;Jul2009, Vol. 12 Issue 7, p21
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on the creation of a transparency task force by the U.S. Food and Drug Administration (FDA) in order to better communicate with the public.
ACCESSION #
42515390

 

Related Articles

  • FDA takes aim at counterfeit drugs. Frederick, James // Drug Store News;10/20/2003, Vol. 25 Issue 14, p9 

    Reports on the plan of the U.S. Food and Drug Administration's Counterfeit Drug Task Force to combat counterfeit drugs in the U.S. Campaign of the task force against growing trade in counterfeit medicines; Features of the agency's Web site; Benefits of the plan for drugstores.

  • Antibacterial task force. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;11/6/2012, Vol. 184 Issue 16, pE825 

    The article reports on an internal task force appointed by the U.S. Food and Drug Administration to tackle the multi-decade decline in the research and development of antibacterial drugs.

  • FDA creates task force to better communicate with public.  // Infectious Diseases in Children;Jul2009, Vol. 22 Issue 7, p29 

    The article reports on the creation of a transparency task force by the U.S. Food and Drug Administration aimed at improving communication with the public.

  • The BPA defense. Mirasol, Feliza // ICIS Chemical Business;6/2/2008, Vol. 273 Issue 22, p24 

    The article reports that the media is being blamed for the bisphenol A (BPA) scare that has panicked several large consumer retail chains to ban products containing the chemical. In April, the U.S. Food and Drug Administration formed a task force to review current research and new information on...

  • FDA asks for input on antibiotic drug development.  // Nature Reviews Drug Discovery;Jul2013, Vol. 12 Issue 7, p494 

    The article reports on a call for public input by the U.S. Food and Drug Administration's (FDA) Antibacterial Drug Development Task Force regarding study design issues and specific bacterial indications.

  • FDA Forms Internal Nanotechnology Task Force. McCormick, Douglas; van Arnum, Patricia // Pharmaceutical Technology;Sep2006, Vol. 30 Issue 9, p22 

    The article reports on the creation of an internal nanotechnology task force by the U.S. Food and Drug Administration (FDA) for determining regulatory approaches to encourage the continued development of innovative FDA-regulated products that use nanotechnology materials. The task force will...

  • FDA creates task force to better communicate with public.  // Hem/Onc Today;6/25/2009, Vol. 10 Issue 12, p40 

    The article reports on the formation of a transparency task force by the U.S. Food and Drug Administration (FDA) to investigate how to improve communication with the public about its activities.

  • …for another it's transparency. Rhea, Shawn // Modern Healthcare;6/8/2009, Vol. 39 Issue 23, p8 

    The article reports on the concerns regarding the creation of a transparency task force by U.S. Food and Drug Administration (FDA)Commissioner Margaret Hamburg in response to a January 21, 2009 memorandum in which President Barack Obama directed government agencies to find ways for making...

  • Federal Task Force Seeks Standards for Immunotherapy Biomarker Studies. Finkelstein, Joel B. // JNCI: Journal of the National Cancer Institute;5/20/2009, Vol. 101 Issue 10, p704 

    The article provides information on a federal task force that aims to build consensus within the cancer community to facilitate biomarkers discovery for cancer immunotherapy. The Task force on Immunotherapy Biomarkers is jointly sponsored by the U.S. Food and Drug Administration and the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics